Last edition
News about
Lupin Acquires VISUfarma, Strengthens Global Specialty Ophthalmology Business
By integrating VISUfarma’s established commercial operations, Lupin aims to tap into the attractive ophthalmology market.
Concept Life Sciences Unveils Major Expansion of UK Drug Discovery Facilities
Concept Life Sciences, a multi-disciplined contract research organisation, has officially opened its newly expanded integrated drug discovery facilities at its Chapel-en-le-Frith headquarters, establishing one of the UK’s largest drug discovery research sites.
Origin can operate as a standalone device and is also planned for integration with FluidAI’s Stream Care – an AI-assisted Surgical Expert Suite. The system has been designed to connect seamlessly to standard surgical drains, continuously delivering bedside pH data visualisation for clinical teams.
USA Tariff Policy Puts USD 3.1 Billion of Singapore Pharma Exports at Risk Amid Ongoing Talks
The USA’s new tariff policy threatens approximately USD 3.1 billion worth of Singapore’s pharmaceutical exports, according to Singaporean authorities, with trade discussions between the two nations currently underway.
In recent statements, the USA government announced plans to impose a 100 per cent tariff on branded pharmaceutical products from firms that have not established USA-based manufacturing, unless construction of such facilities has already begun.
Amgen Commits USD 650 Million to USA Manufacturing Expansion Ahead of Tariff Pressure
Amgen has announced plans to invest USD 650 million in expanding its USA manufacturing network, particularly at its biologics facility in Juncos, Puerto Rico, integrating advanced technologies across its operations.
Camfil Adds New HEPA, ULPA Filter Production Line to Manesar Plant
Sweden-based Camfil, a manufacturer of premium clean air solutions, has expanded its Manesar facility in India with a new production line for HEPA and ULPA filters, boosting supply capacity for hospitals, pharmaceutical cleanrooms, biotechnology labs, and other high-containment facilities.
Bora Biologics Partners with Cipla Subsidiary to Manufacture NYPOZI at San Diego Facility
Bora Biologics has partnered with InvaGen Pharmaceuticals, a wholly owned subsidiary of Cipla Ltd., for the manufacture of NYPOZI at its FDA-registered facility in San Diego, California.
Biolinq Secures FDA De Novo Classification for Wearable Glucose Sensor
San Diego-based health tech startup Biolinq Incorporated has announced that the US Food and Drug Administration (FDA) has granted De Novo Classification for its lead product, Biolinq Shine, a fully autonomous, needle-free glucose sensor.
Dr. Reddy's, Hetero to Produce Affordable Generic Lenacapavir For HIV Prevention by 2027
Indian pharmaceutical companies Dr. Reddy’s Laboratories and Hetero Labs (Hetero) have signed landmark agreements to manufacture generic versions of lenacapavir, a revolutionary long-acting HIV prevention drug, which will be available at roughly USD 40 per patient per year in low- and middle-income countries (LMICs) starting in 2027.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy